Tocqueville Asset Management’s Boston Scientific BSX Stock Holding History

Tocqueville Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$42.6M	Buy	678,172 +234,444	+53%	+$18.8M	0.63%	38
2025 Q4	$42.3M	Sell	443,728 -3,001	-0.7%	-$294K	0.62%	37
2025 Q3	$43.6M	Sell	446,729 -28,466	-6%	-$2.95M	0.64%	35
2025 Q2	$51M	Sell	475,195 -16,802	-3%	-$1.7M	0.78%	29
2025 Q1	$49.6M	Sell	491,997 -4,915	-1%	-$495K	0.81%	30
2024 Q4	$44.4M	Sell	496,912 -5,446	-1%	-$479K	0.7%	35
2024 Q3	$42.1M	Buy	502,358 +1,079	+0.2%	+$85.1K	0.66%	40
2024 Q2	$38.6M	Sell	501,279 -16,776	-3%	-$1.23M	0.64%	41
2024 Q1	$35.5M	Sell	518,055 -4,292	-0.8%	-$276K	0.58%	44
2023 Q4	$30.2M	Sell	522,347 -8,210	-2%	-$438K	0.55%	50
2023 Q3	$28M	Sell	530,557 -52,631	-9%	-$2.76M	0.53%	49
2023 Q2	$31.5M	Sell	583,188 -4,878	-0.8%	-$255K	0.56%	41
2023 Q1	$29.4M	Sell	588,066 -37,765	-6%	-$1.78M	0.56%	44
2022 Q4	$29M	Sell	625,831 -11,125	-2%	-$482K	0.55%	46
2022 Q3	$24.7M	Sell	636,956 -113,975	-15%	-$4.57M	0.5%	52
2022 Q2	$28M	Sell	750,931 -1,800	-0.2%	-$73.3K	0.51%	50
2022 Q1	$33.3M	Buy	752,731 +8,630	+1%	+$374K	0.5%	49
2021 Q4	$31.6M	Buy	744,101 +4,475	+0.6%	+$188K	0.43%	49
2021 Q3	$32.1M	Sell	739,626 -204,920	-22%	-$9.07M	0.48%	47
2021 Q2	$40.4M	Sell	944,546 -9,125	-1%	-$384K	0.58%	37
2021 Q1	$36.9M	Buy	953,671 +96,159	+11%	+$3.64M	0.57%	36
2020 Q4	$30.8M	Buy	857,512 +272,950	+47%	+$9.84M	0.51%	44
2020 Q3	$22.3M	Sell	584,562 -8,890	-1%	-$343K	0.43%	55
2020 Q2	$20.8M	Buy	+593,452	New	+$21.4M	0.43%	54
2020 Q1	–	Sell	-21,600	Closed	-$977K	–	642
2019 Q4	$977K	Sell	21,600 -94,963	-81%	-$3.97M	0.01%	456
2019 Q3	$4.74M	Buy	116,563 +4,178	+4%	+$177K	0.06%	261
2019 Q2	$4.83M	Sell	112,385 -2,765	-2%	-$106K	0.06%	290
2019 Q1	$4.42M	Sell	115,150 -16,710	-13%	-$638K	0.06%	297
2018 Q4	$4.66M	Buy	131,860 +120,360	+1,047%	+$4.37M	0.07%	262
2018 Q3	$443K	Buy	+11,500	New	+$402K	0.01%	644